CTRI/2016/03/006761已完成未知
Evaluation of serum Hepcidin in Oral Submucous Fibrosis - OSMF
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Male and female patients with different grades of Oral Submucous Fibrosis including that with dysplastic changes
排除标准
- •Patients who are systemically ill with chronic inflammatory diseases and patients who have laready been treated for OSMF and are on antioxdiant medications
研究者
相似试验
已完成
2 期
Effect of oral hesperidin supplementation on glycemic and lipidemicin risk factors and inflammatory and oxidant markers in type 2 diabetesDiabetes.E10, E11,Diabetes mellitusIRCT2015081810181N6Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences64
已完成
不适用
Clinical assessment of serum hepcidin isoforms associated with iron homeostasis and erythropoiesis-stimulating agent response in CKD patientsCKDJPRN-UMIN000003427iizuka Hospital400
尚未招募
不适用
Outcome of Tobacco related habits and occurrence of Oral Precancerous ConditioCTRI/2020/02/023507MP Dental College
进行中（未招募）
1 期
Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation versus Sitagliptin in Subjects with Type 2 Diabetes MellitusMedDRA version: 20.1 Level: LLT Classification code 10045242 Term: Type II diabetes mellitus System Organ Class: 100000004861Diabetes Mellitus, Type 2EUCTR2015-005593-38-ATovo Nordisk A/S500
进行中（未招募）
1 期
Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation versus Sitagliptin in Subjects with Type 2 Diabetes MellitusDiabetes Mellitus, Type 2EUCTR2015-005593-38-BEovo Nordisk A/S500